Sigachi Industries Ltd.

₹28.34

-0.5 (-1.6%)

SIGACHI Share Price

Pharmaceuticals & Biotechnology

As on October 1, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 1,079.48 Cr

P/E Ratio-13.25

Dividend Yield0.35 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	28.82	Bearish
10-DMA	29.71	Bearish
20-DMA	31.81	Bearish
50-DMA	29.71	Bearish
100-DMA	26.01	Bullish
200-DMA	24.91	Bullish

Historical Performance

1 Year

-28.4%

3 Years

-29.2%

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	4,778	4,882	3,990	3,020	2,503
Total Expenditure	4,241	3,883	3,223	2,433	1,972
Other Income	83	205	117	67	26
Operating Profit	620	1,205	883	654	557
Interest	139	124	78	43	12
Depreciation	176	158	108	66	29
Profit Before Tax	-877	923	698	545	516
Consolidated Net Profit	-818	696	572	435	400
Adjusted EPS	-2	2	2	1	1

Compounded Sales Growth

10 Years:36.5

5 Years:19.9

3 Years:9.6

TTM:-0.4

Compounded Profit Growth

10 Years:32.6

5 Years:-1.3

3 Years:-8.2

TTM:-16.4

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:-11.1

TTM:-29.4

Return on Equity

10 Years:N/A

5 Years:1.3

3 Years:1.7

last year:-2.1

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	382	382	328	307	307
Total Reserves	4,835	5,626	3,388	2,376	1,970
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	418	480	653	308	76
Other Current Liabilities	741	287	451	143	64
Short Term Borrowings	1,356	1,181	924	395	331
Total Liabilities	8,412	8,462	6,942	3,737	2,868
Capital Work in Progress	306	86	966	349	97
Long Term Loans & Advances	526	480	147	210	117
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	441	149	226	145	146
Total Current Assets	3,893	3,943	3,133	1,774	1,799
Total Assets	8,412	8,462	6,942	3,737	2,868
Adjusted Book Value	14	16	11	9	7

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of -13.25, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of -11.1%, indicating poor shareholder returns.
The stock carries a high beta of 1.3, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹620 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹4778 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 706380.9

No. of Shares: 24925 (Approx)

Performance:-29.4%

-293619.1

NIFTY Performance: -9.9%

1 day Top Gainers